| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Delivery of Health Care, Integrated | 16 | 2023 | 299 | 3.580 |
Why?
|
| Hypertension | 17 | 2023 | 1263 | 2.910 |
Why?
|
| Diabetes Mellitus | 20 | 2022 | 1098 | 2.730 |
Why?
|
| Text Messaging | 5 | 2026 | 182 | 2.650 |
Why?
|
| Medication Adherence | 13 | 2022 | 539 | 2.600 |
Why?
|
| Drug Monitoring | 10 | 2024 | 395 | 2.190 |
Why?
|
| Primary Health Care | 24 | 2022 | 1733 | 2.030 |
Why?
|
| Ambulatory Care Facilities | 7 | 2021 | 265 | 1.970 |
Why?
|
| Appointments and Schedules | 7 | 2023 | 97 | 1.970 |
Why?
|
| Delivery of Health Care | 13 | 2023 | 947 | 1.750 |
Why?
|
| Antihypertensive Agents | 10 | 2023 | 510 | 1.690 |
Why?
|
| Food Supply | 4 | 2018 | 90 | 1.650 |
Why?
|
| Hypoglycemic Agents | 11 | 2017 | 1387 | 1.610 |
Why?
|
| Reminder Systems | 5 | 2021 | 141 | 1.490 |
Why?
|
| Colorado | 51 | 2026 | 4564 | 1.460 |
Why?
|
| Patient Compliance | 8 | 2023 | 588 | 1.450 |
Why?
|
| Telephone | 6 | 2021 | 175 | 1.420 |
Why?
|
| Humans | 198 | 2026 | 144759 | 1.280 |
Why?
|
| Socioeconomic Factors | 23 | 2020 | 1326 | 1.170 |
Why?
|
| Ambulatory Care | 8 | 2024 | 600 | 1.100 |
Why?
|
| Aged | 73 | 2023 | 25913 | 1.070 |
Why?
|
| Female | 123 | 2026 | 78271 | 1.040 |
Why?
|
| Health Maintenance Organizations | 9 | 2018 | 104 | 1.030 |
Why?
|
| Male | 124 | 2026 | 72315 | 1.030 |
Why?
|
| Electronic Health Records | 10 | 2024 | 1173 | 1.010 |
Why?
|
| Patient-Centered Care | 8 | 2023 | 544 | 1.000 |
Why?
|
| Patient Acceptance of Health Care | 9 | 2022 | 885 | 0.950 |
Why?
|
| Mentors | 4 | 2015 | 219 | 0.950 |
Why?
|
| United States | 59 | 2025 | 15966 | 0.940 |
Why?
|
| Hospitalization | 12 | 2023 | 2433 | 0.930 |
Why?
|
| Mass Screening | 8 | 2022 | 1347 | 0.930 |
Why?
|
| Middle Aged | 76 | 2026 | 35875 | 0.900 |
Why?
|
| Retrospective Studies | 40 | 2023 | 17066 | 0.880 |
Why?
|
| Narration | 4 | 2016 | 75 | 0.860 |
Why?
|
| Health Status | 10 | 2022 | 836 | 0.860 |
Why?
|
| Chronic Disease | 16 | 2019 | 1813 | 0.860 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2020 | 2583 | 0.850 |
Why?
|
| Practice Patterns, Physicians' | 10 | 2024 | 1356 | 0.830 |
Why?
|
| Child Health Services | 8 | 2009 | 185 | 0.810 |
Why?
|
| Blood Pressure | 10 | 2023 | 1769 | 0.780 |
Why?
|
| Research | 6 | 2012 | 431 | 0.780 |
Why?
|
| Community-Institutional Relations | 3 | 2009 | 101 | 0.770 |
Why?
|
| Health Insurance Exchanges | 1 | 2022 | 2 | 0.770 |
Why?
|
| Comorbidity | 14 | 2015 | 1658 | 0.760 |
Why?
|
| Cohort Studies | 28 | 2021 | 5960 | 0.750 |
Why?
|
| Comparative Effectiveness Research | 2 | 2015 | 170 | 0.740 |
Why?
|
| Health Services Needs and Demand | 6 | 2019 | 280 | 0.740 |
Why?
|
| Communication | 5 | 2023 | 965 | 0.720 |
Why?
|
| Adult | 64 | 2026 | 40449 | 0.720 |
Why?
|
| Vulnerable Populations | 6 | 2022 | 177 | 0.700 |
Why?
|
| Social Determinants of Health | 3 | 2025 | 301 | 0.700 |
Why?
|
| Biomedical Research | 4 | 2014 | 710 | 0.700 |
Why?
|
| Loneliness | 1 | 2022 | 60 | 0.700 |
Why?
|
| Cardiovascular Diseases | 9 | 2016 | 2168 | 0.700 |
Why?
|
| Proportional Hazards Models | 9 | 2021 | 1325 | 0.700 |
Why?
|
| Health Services Research | 7 | 2019 | 396 | 0.690 |
Why?
|
| Quality Assurance, Health Care | 6 | 2012 | 340 | 0.690 |
Why?
|
| Hyperlipidemias | 3 | 2012 | 122 | 0.680 |
Why?
|
| Sociological Factors | 1 | 2021 | 6 | 0.680 |
Why?
|
| State Health Plans | 4 | 2005 | 28 | 0.670 |
Why?
|
| Risk Factors | 28 | 2022 | 10779 | 0.660 |
Why?
|
| Survivors | 4 | 2010 | 520 | 0.660 |
Why?
|
| Activities of Daily Living | 3 | 2023 | 441 | 0.650 |
Why?
|
| Preventive Health Services | 4 | 2007 | 152 | 0.650 |
Why?
|
| Immunization | 6 | 2009 | 374 | 0.650 |
Why?
|
| Patient Participation | 2 | 2015 | 431 | 0.630 |
Why?
|
| Hypokalemia | 1 | 2020 | 24 | 0.630 |
Why?
|
| Prostatic Neoplasms | 7 | 2014 | 974 | 0.630 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2020 | 16 | 0.630 |
Why?
|
| Urban Population | 7 | 2021 | 491 | 0.610 |
Why?
|
| Hyperkalemia | 1 | 2020 | 35 | 0.610 |
Why?
|
| Quality of Life | 10 | 2019 | 3185 | 0.600 |
Why?
|
| Renal Dialysis | 6 | 2026 | 462 | 0.590 |
Why?
|
| Medical Order Entry Systems | 1 | 2019 | 40 | 0.580 |
Why?
|
| Patient Satisfaction | 10 | 2019 | 704 | 0.570 |
Why?
|
| Long-Acting Reversible Contraception | 1 | 2019 | 34 | 0.570 |
Why?
|
| Social Work | 1 | 2019 | 85 | 0.560 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2015 | 439 | 0.560 |
Why?
|
| Continuity of Patient Care | 4 | 2017 | 291 | 0.560 |
Why?
|
| Kidney Failure, Chronic | 5 | 2026 | 598 | 0.560 |
Why?
|
| Ecosystem | 1 | 2023 | 589 | 0.550 |
Why?
|
| Depression | 5 | 2022 | 1558 | 0.550 |
Why?
|
| Health Behavior | 8 | 2014 | 785 | 0.540 |
Why?
|
| Needs Assessment | 2 | 2019 | 404 | 0.540 |
Why?
|
| Racism | 3 | 2021 | 151 | 0.540 |
Why?
|
| Health Services | 2 | 2012 | 115 | 0.540 |
Why?
|
| Drug Prescriptions | 3 | 2009 | 284 | 0.540 |
Why?
|
| Health Services Accessibility | 9 | 2021 | 1098 | 0.530 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2008 | 124 | 0.530 |
Why?
|
| Office Visits | 4 | 2007 | 90 | 0.530 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 202 | 0.530 |
Why?
|
| Father-Child Relations | 1 | 2017 | 8 | 0.520 |
Why?
|
| Self Administration | 2 | 2016 | 124 | 0.520 |
Why?
|
| Physician-Patient Relations | 7 | 2017 | 585 | 0.520 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2018 | 114 | 0.520 |
Why?
|
| Internal Medicine | 6 | 2008 | 280 | 0.520 |
Why?
|
| Prisons | 3 | 2014 | 84 | 0.520 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2018 | 221 | 0.510 |
Why?
|
| Research Personnel | 2 | 2016 | 186 | 0.500 |
Why?
|
| Diabetes Complications | 2 | 2018 | 222 | 0.500 |
Why?
|
| Employment | 3 | 2008 | 188 | 0.480 |
Why?
|
| Patient Discharge | 1 | 2023 | 983 | 0.480 |
Why?
|
| Games, Recreational | 1 | 2016 | 3 | 0.480 |
Why?
|
| Metformin | 2 | 2017 | 318 | 0.470 |
Why?
|
| Surveys and Questionnaires | 19 | 2023 | 6048 | 0.460 |
Why?
|
| Emergency Service, Hospital | 3 | 2018 | 2310 | 0.460 |
Why?
|
| Prisoners | 3 | 2014 | 143 | 0.460 |
Why?
|
| Insurance, Health | 6 | 2022 | 302 | 0.450 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 265 | 0.450 |
Why?
|
| Physicians | 4 | 2022 | 939 | 0.450 |
Why?
|
| Community Health Centers | 3 | 2012 | 59 | 0.440 |
Why?
|
| Cholesterol, LDL | 6 | 2016 | 358 | 0.440 |
Why?
|
| Neoplasms | 7 | 2014 | 2875 | 0.440 |
Why?
|
| Sickness Impact Profile | 2 | 2005 | 62 | 0.440 |
Why?
|
| Attitude to Health | 4 | 2021 | 436 | 0.440 |
Why?
|
| Problem Solving | 1 | 2016 | 156 | 0.440 |
Why?
|
| Referral and Consultation | 4 | 2018 | 851 | 0.430 |
Why?
|
| Kidney | 4 | 2022 | 1495 | 0.430 |
Why?
|
| Medically Uninsured | 4 | 2007 | 129 | 0.430 |
Why?
|
| Adolescent | 26 | 2025 | 22428 | 0.420 |
Why?
|
| Professional Competence | 1 | 2015 | 98 | 0.420 |
Why?
|
| Competency-Based Education | 1 | 2015 | 79 | 0.420 |
Why?
|
| Self Report | 5 | 2022 | 872 | 0.420 |
Why?
|
| Cooperative Behavior | 2 | 2014 | 465 | 0.420 |
Why?
|
| Computer Communication Networks | 1 | 2014 | 32 | 0.420 |
Why?
|
| Databases as Topic | 1 | 2014 | 71 | 0.410 |
Why?
|
| Aged, 80 and over | 21 | 2021 | 8265 | 0.410 |
Why?
|
| Internet | 6 | 2016 | 699 | 0.410 |
Why?
|
| Attitude of Health Personnel | 6 | 2012 | 1185 | 0.410 |
Why?
|
| Health Care Surveys | 9 | 2013 | 539 | 0.400 |
Why?
|
| Medical Assistance | 2 | 2022 | 13 | 0.400 |
Why?
|
| Health Education | 3 | 2019 | 358 | 0.400 |
Why?
|
| Age Factors | 12 | 2022 | 3333 | 0.400 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 1907 | 0.390 |
Why?
|
| Follow-Up Studies | 11 | 2022 | 5408 | 0.390 |
Why?
|
| Hyperglycemia | 1 | 2017 | 375 | 0.390 |
Why?
|
| Family Practice | 5 | 2008 | 404 | 0.390 |
Why?
|
| Risk Assessment | 9 | 2015 | 3671 | 0.380 |
Why?
|
| Prescription Drugs | 1 | 2014 | 111 | 0.380 |
Why?
|
| Counseling | 2 | 2014 | 408 | 0.380 |
Why?
|
| Qualitative Research | 8 | 2026 | 1671 | 0.370 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 289 | 0.370 |
Why?
|
| Treatment Refusal | 3 | 2007 | 98 | 0.370 |
Why?
|
| Education, Medical, Continuing | 2 | 2025 | 132 | 0.370 |
Why?
|
| Managed Care Programs | 6 | 2017 | 138 | 0.360 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 1180 | 0.360 |
Why?
|
| International Classification of Diseases | 2 | 2015 | 147 | 0.360 |
Why?
|
| Morbidity | 2 | 2015 | 323 | 0.360 |
Why?
|
| Medicare Part C | 1 | 2012 | 31 | 0.360 |
Why?
|
| Overweight | 3 | 2022 | 609 | 0.360 |
Why?
|
| Prostatectomy | 3 | 2006 | 93 | 0.360 |
Why?
|
| Life Style | 1 | 2014 | 479 | 0.350 |
Why?
|
| Pharmaceutical Services | 2 | 2013 | 78 | 0.350 |
Why?
|
| Alaska Natives | 2 | 2025 | 149 | 0.340 |
Why?
|
| Health Status Disparities | 4 | 2022 | 321 | 0.340 |
Why?
|
| Quality of Health Care | 7 | 2021 | 691 | 0.340 |
Why?
|
| Case Management | 2 | 2009 | 67 | 0.340 |
Why?
|
| Terminology as Topic | 1 | 2013 | 255 | 0.340 |
Why?
|
| Young Adult | 18 | 2025 | 14105 | 0.340 |
Why?
|
| Social Adjustment | 1 | 2011 | 64 | 0.340 |
Why?
|
| Faculty, Medical | 2 | 2014 | 302 | 0.340 |
Why?
|
| Odds Ratio | 6 | 2021 | 1075 | 0.340 |
Why?
|
| Pneumococcal Vaccines | 3 | 2008 | 130 | 0.330 |
Why?
|
| Hypolipidemic Agents | 1 | 2011 | 88 | 0.330 |
Why?
|
| Infant | 20 | 2024 | 10034 | 0.330 |
Why?
|
| Insulin | 3 | 2017 | 2507 | 0.330 |
Why?
|
| Anticholesteremic Agents | 1 | 2012 | 152 | 0.320 |
Why?
|
| Colonoscopy | 4 | 2023 | 261 | 0.320 |
Why?
|
| Undocumented Immigrants | 2 | 2023 | 64 | 0.320 |
Why?
|
| Kidney Diseases | 2 | 2011 | 427 | 0.320 |
Why?
|
| Registries | 10 | 2015 | 2385 | 0.310 |
Why?
|
| Workplace | 2 | 2010 | 274 | 0.310 |
Why?
|
| Patient Navigation | 3 | 2026 | 104 | 0.310 |
Why?
|
| Healthcare Disparities | 6 | 2022 | 727 | 0.310 |
Why?
|
| Social Support | 4 | 2019 | 652 | 0.310 |
Why?
|
| Self Care | 4 | 2008 | 389 | 0.310 |
Why?
|
| Bell Palsy | 1 | 2009 | 9 | 0.310 |
Why?
|
| Cross-Sectional Studies | 17 | 2022 | 5868 | 0.310 |
Why?
|
| Osteoarthritis | 3 | 2008 | 196 | 0.300 |
Why?
|
| Minority Groups | 3 | 2022 | 282 | 0.300 |
Why?
|
| Models, Biological | 1 | 2017 | 1821 | 0.300 |
Why?
|
| Isosorbide Dinitrate | 1 | 2009 | 3 | 0.300 |
Why?
|
| Hydralazine | 1 | 2009 | 6 | 0.300 |
Why?
|
| Multivariate Analysis | 11 | 2014 | 1539 | 0.290 |
Why?
|
| Urban Health | 2 | 2006 | 96 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 4 | 2014 | 1560 | 0.290 |
Why?
|
| Health Status Indicators | 2 | 2014 | 166 | 0.290 |
Why?
|
| Clinical Competence | 4 | 2014 | 1244 | 0.290 |
Why?
|
| Heart Failure | 7 | 2015 | 2323 | 0.290 |
Why?
|
| Insurance Coverage | 3 | 2007 | 239 | 0.290 |
Why?
|
| Depressive Disorder | 2 | 2011 | 387 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2730 | 0.290 |
Why?
|
| Fellowships and Scholarships | 3 | 2003 | 357 | 0.290 |
Why?
|
| Time Factors | 12 | 2015 | 7173 | 0.280 |
Why?
|
| Vaccination | 3 | 2022 | 1423 | 0.280 |
Why?
|
| Immunization Programs | 4 | 2007 | 194 | 0.280 |
Why?
|
| Population Surveillance | 5 | 2019 | 485 | 0.280 |
Why?
|
| Health Policy | 3 | 2007 | 400 | 0.280 |
Why?
|
| Child, Preschool | 18 | 2024 | 11787 | 0.280 |
Why?
|
| Interprofessional Relations | 3 | 2014 | 281 | 0.270 |
Why?
|
| Prevalence | 10 | 2025 | 2834 | 0.270 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2012 | 768 | 0.270 |
Why?
|
| Indians, North American | 2 | 2025 | 647 | 0.270 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 276 | 0.270 |
Why?
|
| Electrocardiography | 2 | 2008 | 662 | 0.270 |
Why?
|
| Social Values | 2 | 2021 | 40 | 0.270 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2007 | 24 | 0.270 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 2637 | 0.270 |
Why?
|
| Physician Impairment | 1 | 2007 | 15 | 0.270 |
Why?
|
| Quality Improvement | 4 | 2025 | 1289 | 0.270 |
Why?
|
| Survival Analysis | 2 | 2008 | 1382 | 0.260 |
Why?
|
| Hypoglycemia | 3 | 2017 | 477 | 0.260 |
Why?
|
| Drug Overdose | 1 | 2012 | 370 | 0.260 |
Why?
|
| Drug Therapy, Combination | 3 | 2018 | 1047 | 0.250 |
Why?
|
| Models, Statistical | 3 | 2014 | 681 | 0.250 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 331 | 0.250 |
Why?
|
| Child Care | 1 | 2007 | 36 | 0.250 |
Why?
|
| Health Surveys | 5 | 2015 | 518 | 0.250 |
Why?
|
| Information Dissemination | 2 | 2016 | 223 | 0.250 |
Why?
|
| After-Hours Care | 1 | 2006 | 16 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3863 | 0.250 |
Why?
|
| Hospitals, University | 2 | 2008 | 176 | 0.240 |
Why?
|
| Medicare | 4 | 2018 | 886 | 0.240 |
Why?
|
| Blood Glucose | 4 | 2015 | 2327 | 0.240 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 478 | 0.240 |
Why?
|
| Triage | 2 | 2006 | 249 | 0.240 |
Why?
|
| Linear Models | 5 | 2011 | 854 | 0.240 |
Why?
|
| Policy Making | 2 | 2005 | 82 | 0.240 |
Why?
|
| Community Health Services | 2 | 2008 | 233 | 0.240 |
Why?
|
| Urology | 1 | 2006 | 64 | 0.230 |
Why?
|
| Clinical Medicine | 1 | 2005 | 26 | 0.230 |
Why?
|
| Dyslipidemias | 1 | 2007 | 181 | 0.230 |
Why?
|
| Education, Continuing | 1 | 2025 | 41 | 0.230 |
Why?
|
| Emergencies | 1 | 2006 | 175 | 0.220 |
Why?
|
| Value of Life | 1 | 2005 | 19 | 0.220 |
Why?
|
| Marital Status | 1 | 2005 | 46 | 0.220 |
Why?
|
| Bone Density | 1 | 2009 | 482 | 0.220 |
Why?
|
| Staff Development | 1 | 2025 | 61 | 0.220 |
Why?
|
| Work | 1 | 2004 | 23 | 0.220 |
Why?
|
| Health Promotion | 2 | 2009 | 774 | 0.220 |
Why?
|
| Incidence | 7 | 2015 | 2879 | 0.220 |
Why?
|
| Anxiety | 3 | 2022 | 1109 | 0.220 |
Why?
|
| Diabetes, Gestational | 2 | 2022 | 321 | 0.210 |
Why?
|
| Community Health Workers | 1 | 2026 | 87 | 0.210 |
Why?
|
| Carcinoma | 1 | 2006 | 228 | 0.210 |
Why?
|
| Weight Gain | 2 | 2026 | 556 | 0.210 |
Why?
|
| Foot Diseases | 1 | 2004 | 17 | 0.210 |
Why?
|
| Foot Deformities | 1 | 2004 | 10 | 0.210 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 2925 | 0.210 |
Why?
|
| Glomerular Filtration Rate | 4 | 2018 | 760 | 0.210 |
Why?
|
| Interrupted Time Series Analysis | 2 | 2024 | 75 | 0.200 |
Why?
|
| Insurance Claim Review | 3 | 2015 | 83 | 0.200 |
Why?
|
| Antiviral Agents | 1 | 2009 | 767 | 0.200 |
Why?
|
| Career Choice | 2 | 2003 | 237 | 0.200 |
Why?
|
| Program Evaluation | 5 | 2023 | 948 | 0.200 |
Why?
|
| Poverty | 5 | 2025 | 529 | 0.200 |
Why?
|
| Child, Hospitalized | 1 | 2003 | 54 | 0.190 |
Why?
|
| Colorectal Neoplasms | 4 | 2014 | 845 | 0.190 |
Why?
|
| Substance-Related Disorders | 2 | 2012 | 1094 | 0.190 |
Why?
|
| Interviews as Topic | 6 | 2011 | 901 | 0.190 |
Why?
|
| Child | 16 | 2024 | 22633 | 0.190 |
Why?
|
| Medical Staff | 1 | 2002 | 17 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2017 | 3890 | 0.190 |
Why?
|
| Physician's Role | 1 | 2004 | 218 | 0.190 |
Why?
|
| Egg Hypersensitivity | 1 | 2022 | 28 | 0.190 |
Why?
|
| Patient Readmission | 2 | 2023 | 758 | 0.190 |
Why?
|
| Hospitals, Pediatric | 1 | 2006 | 556 | 0.190 |
Why?
|
| Medical Records Systems, Computerized | 3 | 2008 | 95 | 0.180 |
Why?
|
| Compassion Fatigue | 1 | 2022 | 31 | 0.180 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 529 | 0.180 |
Why?
|
| Training Support | 1 | 2002 | 36 | 0.180 |
Why?
|
| Eczema | 1 | 2022 | 66 | 0.180 |
Why?
|
| Phobic Disorders | 1 | 2022 | 35 | 0.180 |
Why?
|
| Community-Acquired Infections | 1 | 2024 | 174 | 0.180 |
Why?
|
| Health Fairs | 1 | 2002 | 10 | 0.180 |
Why?
|
| Health Facilities | 1 | 2022 | 85 | 0.180 |
Why?
|
| Demography | 4 | 2008 | 288 | 0.180 |
Why?
|
| Disease Management | 4 | 2015 | 645 | 0.170 |
Why?
|
| Meals | 1 | 2023 | 130 | 0.170 |
Why?
|
| Awards and Prizes | 1 | 2002 | 70 | 0.170 |
Why?
|
| Acculturation | 2 | 2012 | 54 | 0.170 |
Why?
|
| Infant, Newborn | 7 | 2009 | 6429 | 0.170 |
Why?
|
| Behavior Therapy | 1 | 2004 | 299 | 0.170 |
Why?
|
| Data Collection | 5 | 2012 | 633 | 0.170 |
Why?
|
| Renal Insufficiency | 1 | 2023 | 168 | 0.170 |
Why?
|
| New Mexico | 1 | 2021 | 99 | 0.170 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 780 | 0.160 |
Why?
|
| Complementary Therapies | 1 | 2002 | 94 | 0.160 |
Why?
|
| Peanut Hypersensitivity | 1 | 2022 | 143 | 0.160 |
Why?
|
| Culturally Competent Care | 1 | 2021 | 74 | 0.160 |
Why?
|
| Regression Analysis | 5 | 2007 | 1003 | 0.160 |
Why?
|
| Pyelonephritis | 1 | 2020 | 11 | 0.160 |
Why?
|
| Prognosis | 5 | 2017 | 4282 | 0.160 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 83 | 0.160 |
Why?
|
| Cystitis | 1 | 2020 | 23 | 0.160 |
Why?
|
| Body Mass Index | 3 | 2025 | 2438 | 0.160 |
Why?
|
| Electronic Mail | 2 | 2013 | 61 | 0.160 |
Why?
|
| Cephalexin | 1 | 2020 | 14 | 0.160 |
Why?
|
| Communication Barriers | 1 | 2021 | 124 | 0.160 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 42 | 0.160 |
Why?
|
| Transportation | 1 | 2020 | 54 | 0.150 |
Why?
|
| Geography | 1 | 2020 | 203 | 0.150 |
Why?
|
| Potassium | 1 | 2020 | 152 | 0.150 |
Why?
|
| Information Services | 1 | 2019 | 46 | 0.150 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2022 | 251 | 0.150 |
Why?
|
| Internship and Residency | 4 | 2006 | 1257 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 373 | 0.150 |
Why?
|
| Obesity | 3 | 2025 | 3077 | 0.140 |
Why?
|
| Smoking | 3 | 2015 | 1472 | 0.140 |
Why?
|
| Patient Selection | 3 | 2009 | 719 | 0.140 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 2947 | 0.140 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2018 | 8 | 0.140 |
Why?
|
| Pneumonia | 1 | 2024 | 631 | 0.140 |
Why?
|
| Contraception Behavior | 1 | 2019 | 107 | 0.140 |
Why?
|
| Cluster Analysis | 3 | 2011 | 521 | 0.140 |
Why?
|
| Secondary Prevention | 2 | 2017 | 254 | 0.140 |
Why?
|
| Wounds and Injuries | 2 | 2006 | 956 | 0.130 |
Why?
|
| Logistic Models | 4 | 2012 | 2117 | 0.130 |
Why?
|
| Nomograms | 2 | 2014 | 59 | 0.130 |
Why?
|
| Northwestern United States | 1 | 2017 | 58 | 0.130 |
Why?
|
| Probability | 3 | 2010 | 310 | 0.130 |
Why?
|
| Pandemics | 2 | 2023 | 1694 | 0.130 |
Why?
|
| Patients | 2 | 2011 | 180 | 0.130 |
Why?
|
| Calcium Channel Blockers | 1 | 2018 | 165 | 0.130 |
Why?
|
| Prospective Studies | 6 | 2023 | 7990 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 1462 | 0.130 |
Why?
|
| Organizational Case Studies | 2 | 2025 | 69 | 0.120 |
Why?
|
| Epidemiological Monitoring | 2 | 2015 | 69 | 0.120 |
Why?
|
| Attitude to Death | 1 | 2017 | 73 | 0.120 |
Why?
|
| Malnutrition | 1 | 2018 | 86 | 0.120 |
Why?
|
| Learning | 1 | 2021 | 452 | 0.120 |
Why?
|
| Minnesota | 1 | 2017 | 169 | 0.120 |
Why?
|
| Critical Care | 1 | 2022 | 695 | 0.120 |
Why?
|
| Blood Pressure Determination | 2 | 2015 | 144 | 0.120 |
Why?
|
| Utilization Review | 2 | 2009 | 39 | 0.120 |
Why?
|
| Physicians, Family | 2 | 2008 | 173 | 0.120 |
Why?
|
| Peer Group | 1 | 2019 | 257 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 1414 | 0.120 |
Why?
|
| Mental Disorders | 2 | 2008 | 1168 | 0.120 |
Why?
|
| Burnout, Professional | 1 | 2022 | 484 | 0.120 |
Why?
|
| Asthma | 2 | 2022 | 1767 | 0.110 |
Why?
|
| Information Seeking Behavior | 1 | 2016 | 38 | 0.110 |
Why?
|
| Pediatric Obesity | 1 | 2022 | 637 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2007 | 2919 | 0.110 |
Why?
|
| Total Quality Management | 2 | 2007 | 57 | 0.110 |
Why?
|
| Arizona | 1 | 2014 | 81 | 0.110 |
Why?
|
| Survival Rate | 4 | 2015 | 2089 | 0.110 |
Why?
|
| Residence Characteristics | 1 | 2017 | 377 | 0.110 |
Why?
|
| Cost Sharing | 2 | 2015 | 20 | 0.110 |
Why?
|
| House Calls | 2 | 2009 | 154 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 109 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2010 | 2115 | 0.100 |
Why?
|
| Organizational Policy | 1 | 2014 | 76 | 0.100 |
Why?
|
| Computer Security | 1 | 2014 | 25 | 0.100 |
Why?
|
| SEER Program | 3 | 2014 | 224 | 0.100 |
Why?
|
| Privacy | 1 | 2014 | 41 | 0.100 |
Why?
|
| Family | 3 | 2020 | 679 | 0.100 |
Why?
|
| Exercise | 3 | 2021 | 2201 | 0.100 |
Why?
|
| Organizational Innovation | 1 | 2014 | 120 | 0.100 |
Why?
|
| Confidentiality | 1 | 2014 | 79 | 0.100 |
Why?
|
| Sulfonylurea Compounds | 1 | 2013 | 51 | 0.100 |
Why?
|
| Eligibility Determination | 2 | 2004 | 68 | 0.100 |
Why?
|
| Disease Progression | 2 | 2011 | 2847 | 0.100 |
Why?
|
| Decision Making | 3 | 2006 | 975 | 0.100 |
Why?
|
| Patient Access to Records | 1 | 2013 | 20 | 0.100 |
Why?
|
| Stereotyped Behavior | 1 | 2012 | 22 | 0.100 |
Why?
|
| Diabetic Angiopathies | 1 | 2015 | 263 | 0.100 |
Why?
|
| Influenza Vaccines | 2 | 2008 | 529 | 0.100 |
Why?
|
| Natural Language Processing | 1 | 2014 | 103 | 0.090 |
Why?
|
| Social Media | 1 | 2016 | 171 | 0.090 |
Why?
|
| Parents | 3 | 2006 | 1403 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2016 | 582 | 0.090 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 488 | 0.090 |
Why?
|
| Anti-HIV Agents | 2 | 2011 | 888 | 0.090 |
Why?
|
| User-Computer Interface | 2 | 2012 | 164 | 0.090 |
Why?
|
| Telemedicine | 1 | 2022 | 945 | 0.090 |
Why?
|
| Reimbursement, Incentive | 1 | 2012 | 42 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2011 | 278 | 0.090 |
Why?
|
| Risk | 2 | 2022 | 911 | 0.090 |
Why?
|
| Medicaid | 2 | 2009 | 461 | 0.090 |
Why?
|
| Program Development | 2 | 2019 | 370 | 0.090 |
Why?
|
| Nurses | 2 | 2006 | 178 | 0.090 |
Why?
|
| Remote Consultation | 1 | 2013 | 66 | 0.090 |
Why?
|
| Pharmacists | 1 | 2014 | 240 | 0.090 |
Why?
|
| Teaching | 2 | 2006 | 236 | 0.090 |
Why?
|
| Pulmonary Fibrosis | 1 | 2016 | 395 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 405 | 0.090 |
Why?
|
| Cultural Competency | 2 | 2013 | 93 | 0.090 |
Why?
|
| Pediatrics | 3 | 2006 | 1114 | 0.090 |
Why?
|
| Medical Record Linkage | 1 | 2012 | 68 | 0.090 |
Why?
|
| Forensic Psychiatry | 1 | 2011 | 29 | 0.090 |
Why?
|
| Medical Informatics | 1 | 2012 | 97 | 0.090 |
Why?
|
| Urban Health Services | 2 | 2009 | 70 | 0.090 |
Why?
|
| Diabetic Nephropathies | 1 | 2015 | 318 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 547 | 0.080 |
Why?
|
| HIV Infections | 3 | 2011 | 3154 | 0.080 |
Why?
|
| Pregnancy | 3 | 2022 | 7190 | 0.080 |
Why?
|
| Primary Prevention | 2 | 2013 | 220 | 0.080 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 207 | 0.080 |
Why?
|
| Birth Weight | 2 | 2022 | 522 | 0.080 |
Why?
|
| Audiovisual Aids | 1 | 2009 | 11 | 0.080 |
Why?
|
| Medicare Part D | 1 | 2010 | 23 | 0.080 |
Why?
|
| Outpatients | 2 | 2024 | 442 | 0.080 |
Why?
|
| Computer-Assisted Instruction | 1 | 2009 | 71 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2012 | 11679 | 0.070 |
Why?
|
| Risk-Taking | 1 | 2011 | 328 | 0.070 |
Why?
|
| Self Disclosure | 1 | 2008 | 62 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 653 | 0.070 |
Why?
|
| Drug Resistance, Viral | 1 | 2009 | 122 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2014 | 790 | 0.070 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2008 | 39 | 0.070 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 46 | 0.070 |
Why?
|
| Health Services for the Aged | 1 | 2008 | 70 | 0.070 |
Why?
|
| Mental Health Services | 2 | 2004 | 473 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2009 | 390 | 0.070 |
Why?
|
| Safety | 2 | 2007 | 356 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2008 | 101 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2013 | 1486 | 0.060 |
Why?
|
| Psychology | 1 | 2008 | 88 | 0.060 |
Why?
|
| Sex Factors | 4 | 2020 | 2112 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2008 | 284 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 1053 | 0.060 |
Why?
|
| Geriatrics | 1 | 2008 | 96 | 0.060 |
Why?
|
| Correspondence as Topic | 1 | 2007 | 16 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2008 | 282 | 0.060 |
Why?
|
| Curriculum | 1 | 2014 | 1059 | 0.060 |
Why?
|
| Pamphlets | 1 | 2006 | 26 | 0.060 |
Why?
|
| Anecdotes as Topic | 1 | 2006 | 7 | 0.060 |
Why?
|
| Accident Prevention | 1 | 2006 | 26 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 1 | 2006 | 35 | 0.060 |
Why?
|
| Erectile Dysfunction | 1 | 2006 | 38 | 0.060 |
Why?
|
| Attitude | 2 | 2005 | 260 | 0.060 |
Why?
|
| Culture | 1 | 2007 | 125 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2007 | 386 | 0.060 |
Why?
|
| Urinary Incontinence | 1 | 2006 | 64 | 0.060 |
Why?
|
| Models, Organizational | 1 | 2007 | 144 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2009 | 236 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2008 | 321 | 0.060 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2008 | 154 | 0.060 |
Why?
|
| Patient Dropouts | 1 | 2006 | 65 | 0.060 |
Why?
|
| Cholesterol | 1 | 2007 | 406 | 0.060 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 80 | 0.060 |
Why?
|
| Postal Service | 3 | 2015 | 27 | 0.060 |
Why?
|
| Mental Health | 1 | 2012 | 790 | 0.060 |
Why?
|
| Alcoholism | 1 | 2012 | 817 | 0.050 |
Why?
|
| Hospital Costs | 1 | 2005 | 124 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1306 | 0.050 |
Why?
|
| Chicago | 1 | 2004 | 61 | 0.050 |
Why?
|
| Los Angeles | 1 | 2004 | 76 | 0.050 |
Why?
|
| Boston | 1 | 2004 | 92 | 0.050 |
Why?
|
| Podiatry | 1 | 2004 | 6 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2010 | 717 | 0.050 |
Why?
|
| Drug Costs | 1 | 2005 | 116 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2007 | 270 | 0.050 |
Why?
|
| Age Distribution | 1 | 2005 | 403 | 0.050 |
Why?
|
| Herpes Zoster | 1 | 2008 | 315 | 0.050 |
Why?
|
| Suicide | 1 | 2012 | 720 | 0.050 |
Why?
|
| Educational Status | 1 | 2006 | 467 | 0.050 |
Why?
|
| Brachytherapy | 1 | 2005 | 134 | 0.050 |
Why?
|
| Happiness | 1 | 2004 | 23 | 0.050 |
Why?
|
| Algorithms | 2 | 2011 | 1837 | 0.050 |
Why?
|
| Fee-for-Service Plans | 1 | 2004 | 98 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2008 | 1720 | 0.050 |
Why?
|
| United Kingdom | 1 | 2005 | 338 | 0.050 |
Why?
|
| Goals | 1 | 2005 | 183 | 0.050 |
Why?
|
| Mortality | 1 | 2006 | 375 | 0.050 |
Why?
|
| Public Health Practice | 1 | 2004 | 63 | 0.050 |
Why?
|
| Social Class | 1 | 2005 | 268 | 0.050 |
Why?
|
| Specialization | 1 | 2004 | 136 | 0.050 |
Why?
|
| Self Concept | 1 | 2005 | 253 | 0.050 |
Why?
|
| Echinacea | 1 | 2003 | 2 | 0.050 |
Why?
|
| Medical Indigency | 1 | 2003 | 11 | 0.050 |
Why?
|
| Public Health Informatics | 1 | 2003 | 10 | 0.050 |
Why?
|
| Self-Help Groups | 1 | 2023 | 37 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 920 | 0.050 |
Why?
|
| Drug Labeling | 1 | 2003 | 37 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2004 | 156 | 0.050 |
Why?
|
| Hospitals, Urban | 1 | 2003 | 144 | 0.050 |
Why?
|
| HIV-1 | 1 | 2009 | 896 | 0.050 |
Why?
|
| Herpes Genitalis | 1 | 2002 | 17 | 0.050 |
Why?
|
| Professional Autonomy | 1 | 2002 | 32 | 0.050 |
Why?
|
| Home Care Agencies | 1 | 2002 | 7 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2002 | 27 | 0.050 |
Why?
|
| Truth Disclosure | 1 | 2003 | 50 | 0.050 |
Why?
|
| Hotlines | 1 | 2002 | 32 | 0.050 |
Why?
|
| Medicine | 1 | 2004 | 125 | 0.050 |
Why?
|
| Financing, Personal | 1 | 2002 | 27 | 0.050 |
Why?
|
| Fetal Macrosomia | 1 | 2022 | 62 | 0.050 |
Why?
|
| Antimicrobial Stewardship | 1 | 2024 | 129 | 0.040 |
Why?
|
| Drug Utilization | 2 | 2015 | 166 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2021 | 80 | 0.040 |
Why?
|
| Arachis | 1 | 2022 | 108 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2002 | 143 | 0.040 |
Why?
|
| Publishing | 1 | 2002 | 114 | 0.040 |
Why?
|
| Cause of Death | 2 | 2015 | 471 | 0.040 |
Why?
|
| Prednisone | 1 | 2022 | 221 | 0.040 |
Why?
|
| Social Isolation | 1 | 2021 | 72 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2021 | 312 | 0.040 |
Why?
|
| Biomarkers | 1 | 2012 | 4271 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 732 | 0.040 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2002 | 166 | 0.040 |
Why?
|
| ROC Curve | 2 | 2014 | 614 | 0.040 |
Why?
|
| Writing | 1 | 2021 | 100 | 0.040 |
Why?
|
| Professional-Patient Relations | 1 | 2021 | 154 | 0.040 |
Why?
|
| Psychometrics | 1 | 2004 | 734 | 0.040 |
Why?
|
| Adult Children | 1 | 2020 | 26 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 1137 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2002 | 314 | 0.040 |
Why?
|
| Emergency Medicine | 1 | 2002 | 261 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2003 | 541 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2002 | 281 | 0.040 |
Why?
|
| Health Literacy | 1 | 2021 | 184 | 0.040 |
Why?
|
| Social Stigma | 1 | 2021 | 171 | 0.040 |
Why?
|
| Home Care Services | 1 | 2002 | 280 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 2 | 2014 | 335 | 0.040 |
Why?
|
| Geographic Mapping | 1 | 2018 | 29 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2019 | 1095 | 0.030 |
Why?
|
| Research Design | 1 | 2004 | 1135 | 0.030 |
Why?
|
| Therapeutic Misconception | 1 | 2017 | 1 | 0.030 |
Why?
|
| Multilevel Analysis | 1 | 2017 | 36 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2006 | 1152 | 0.030 |
Why?
|
| Censuses | 1 | 2017 | 35 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2012 | 333 | 0.030 |
Why?
|
| Veterans | 1 | 2009 | 1603 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2014 | 1886 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2003 | 3604 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 696 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 2002 | 569 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 78 | 0.030 |
Why?
|
| State Government | 1 | 2014 | 46 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 121 | 0.030 |
Why?
|
| Albuminuria | 1 | 2015 | 190 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1266 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2014 | 166 | 0.020 |
Why?
|
| Terminally Ill | 1 | 2013 | 41 | 0.020 |
Why?
|
| Caregivers | 1 | 2020 | 1049 | 0.020 |
Why?
|
| Trust | 1 | 2012 | 153 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 117 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 551 | 0.020 |
Why?
|
| Affect | 1 | 2012 | 318 | 0.020 |
Why?
|
| Multilingualism | 1 | 2009 | 29 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2010 | 114 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2009 | 166 | 0.020 |
Why?
|
| Observation | 1 | 2008 | 54 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2008 | 29 | 0.020 |
Why?
|
| Health Care Rationing | 1 | 2007 | 59 | 0.020 |
Why?
|
| Private Sector | 1 | 2007 | 49 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 965 | 0.020 |
Why?
|
| Personnel Turnover | 1 | 2007 | 42 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 1209 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2009 | 251 | 0.020 |
Why?
|
| Domestic Violence | 1 | 2006 | 51 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2007 | 259 | 0.010 |
Why?
|
| Stroke | 1 | 2015 | 1256 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2006 | 80 | 0.010 |
Why?
|
| Herpesvirus 3, Human | 1 | 2008 | 336 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 1833 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2006 | 847 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2009 | 684 | 0.010 |
Why?
|
| Spironolactone | 1 | 2003 | 39 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2008 | 589 | 0.010 |
Why?
|
| Patient Care | 1 | 2004 | 118 | 0.010 |
Why?
|
| Poverty Areas | 1 | 2002 | 42 | 0.010 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2003 | 68 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2002 | 172 | 0.010 |
Why?
|
| Community Health Nursing | 1 | 2002 | 63 | 0.010 |
Why?
|
| Risk Adjustment | 1 | 2002 | 85 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 250 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 427 | 0.010 |
Why?
|
| Emergency Treatment | 1 | 2002 | 124 | 0.010 |
Why?
|
| Education, Medical | 1 | 2005 | 274 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2003 | 392 | 0.010 |
Why?
|
| Rural Population | 1 | 2004 | 650 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2003 | 557 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 3409 | 0.010 |
Why?
|